Venture Capital Market Intelligence
AI dominance and a historic SpaceX listing define an increasingly concentrated venture landscape
AI continued to define venture capital in Q2 2026, driving the overwhelming majority of deal value as megadeals crowded out smaller financings and a landmark IPO reshaped the exit landscape. Fund formation contracted even as headline capital raised held roughly steady, concentrating dollars among a smaller set of established managers. This report examines what these shifts mean for valuations, fundraising, and liquidity planning across the venture ecosystem.
Q2 2026 Report
What's Inside
- How AI's dominance of deal value is compressing the space available for smaller financings
- Which regions and stages are capturing share as capital concentrates around key tech hubs
- Why fund formation is contracting even as headline capital-raised figures hold steady
- What continued concentration among established managers means for emerging fund vehicles
- How median pre-money valuations compare to prior peaks across funding stages
- What first-time financing activity signals about the broader health of early-stage investing
- How a landmark IPO reshaped exit value for the quarter, and what it doesn't tell us about broader liquidity
- What shifting merger enforcement and tax policy mean for exit planning and investor returns
Download the Report
Q2 2026 Venture Capital Quarterly Update
By downloading you’ll also receive future quarterly Venture Capital reports and relevant market insights from Houlihan Capital. Unsubscribe anytime.
Our Experience
Venture Capital Expertise
Houlihan Capital advises venture-backed companies, funds, and institutional investors across the venture lifecycle. Our work spans independent valuations, transaction advisory, and strategic guidance for capital raises, liquidity events, and portfolio decision-making.
Venture Capital Services:
Portfolio Valuations | Fairness Opinions | Transaction Advisory | Exit Readiness | LP & GP Support
Questions? Contact our venture capital specialists at info@houlihancapital.com or 312.450.8600
This content is for informational purposes only and does not constitute investment advice.
More from Houlihan Capital
Explore Related Quarterly Reports
Healthcare | Q1 2026
Deal activity, reimbursement developments, and valuation trends across healthcare services
Cryptocurrency & Digital Assets | Q1 2026
Market performance, regulatory developments, and deal activity across cryptocurrency and digital assets
SPAC | Q1 2026
Deal structures, post-merger performance, and regulatory developments across SPAC transactions
